It is used for the treatment of bleeding oesophageal varices.
The global Terlipressin Acetate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Terlipressin Acetate market research.
Key manufacturers engaged in the Terlipressin Acetate industry include Sun Pharmaceutical Industries, King Sun Chemical & Pharmaceutical, Hybio Pharmaceutical, Harbin Jixianglong and Qingdao Guoda, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Terlipressin Acetate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Terlipressin Acetate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Terlipressin Acetate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sun Pharmaceutical Industries
King Sun Chemical & Pharmaceutical
Hybio Pharmaceutical
Harbin Jixianglong
Qingdao Guoda
Segment by Type
Above 98%
Below 98%
Segment by Application
Injection
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Terlipressin Acetate report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Âé¶¹Ô´´ Channel and Customer Analysis
Chapter 8: Âé¶¹Ô´´ Opportunities and Challenges
Chapter 9: Âé¶¹Ô´´ Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Terlipressin Acetate Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Terlipressin Acetate
1.2 Terlipressin Acetate Segment by Type
1.2.1 Global Terlipressin Acetate Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 Above 98%
1.2.3 Below 98%
1.3 Terlipressin Acetate Segment by Application
1.3.1 Global Terlipressin Acetate Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Injection
1.3.3 Other
1.4 Global Terlipressin Acetate Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Terlipressin Acetate Revenue 2018-2029
1.4.2 Global Terlipressin Acetate Sales 2018-2029
1.4.3 Global Terlipressin Acetate Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Terlipressin Acetate Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Terlipressin Acetate Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Terlipressin Acetate Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Terlipressin Acetate Average Price by Manufacturers (2018-2023)
2.4 Global Terlipressin Acetate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Terlipressin Acetate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terlipressin Acetate, Product Type & Application
2.7 Terlipressin Acetate Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Terlipressin Acetate Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Terlipressin Acetate Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Terlipressin Acetate Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Terlipressin Acetate Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Terlipressin Acetate Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Terlipressin Acetate Global Terlipressin Acetate Sales by Region: 2018-2029
3.2.1 Global Terlipressin Acetate Sales by Region: 2018-2023
3.2.2 Global Terlipressin Acetate Sales by Region: 2024-2029
3.3 Global Terlipressin Acetate Global Terlipressin Acetate Revenue by Region: 2018-2029
3.3.1 Global Terlipressin Acetate Revenue by Region: 2018-2023
3.3.2 Global Terlipressin Acetate Revenue by Region: 2024-2029
3.4 North America Terlipressin Acetate Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Terlipressin Acetate Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Terlipressin Acetate Sales by Country (2018-2029)
3.4.3 North America Terlipressin Acetate Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Terlipressin Acetate Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Terlipressin Acetate Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Terlipressin Acetate Sales by Country (2018-2029)
3.5.3 Europe Terlipressin Acetate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terlipressin Acetate Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Terlipressin Acetate Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Terlipressin Acetate Sales by Country (2018-2029)
3.6.3 Asia Pacific Terlipressin Acetate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Terlipressin Acetate Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Terlipressin Acetate Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Terlipressin Acetate Sales by Country (2018-2029)
3.7.3 Latin America Terlipressin Acetate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terlipressin Acetate Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Terlipressin Acetate Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Terlipressin Acetate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Terlipressin Acetate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Terlipressin Acetate Sales by Type (2018-2029)
4.1.1 Global Terlipressin Acetate Sales by Type (2018-2023)
4.1.2 Global Terlipressin Acetate Sales by Type (2024-2029)
4.1.3 Global Terlipressin Acetate Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Terlipressin Acetate Revenue by Type (2018-2029)
4.2.1 Global Terlipressin Acetate Revenue by Type (2018-2023)
4.2.2 Global Terlipressin Acetate Revenue by Type (2024-2029)
4.2.3 Global Terlipressin Acetate Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Terlipressin Acetate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Terlipressin Acetate Sales by Application (2018-2029)
5.1.1 Global Terlipressin Acetate Sales by Application (2018-2023)
5.1.2 Global Terlipressin Acetate Sales by Application (2024-2029)
5.1.3 Global Terlipressin Acetate Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Terlipressin Acetate Revenue by Application (2018-2029)
5.2.1 Global Terlipressin Acetate Revenue by Application (2018-2023)
5.2.2 Global Terlipressin Acetate Revenue by Application (2024-2029)
5.2.3 Global Terlipressin Acetate Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Terlipressin Acetate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sun Pharmaceutical Industries
6.1.1 Sun Pharmaceutical Industries Corporation Information
6.1.2 Sun Pharmaceutical Industries Description and Business Overview
6.1.3 Sun Pharmaceutical Industries Terlipressin Acetate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sun Pharmaceutical Industries Terlipressin Acetate Product Portfolio
6.1.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.2 King Sun Chemical & Pharmaceutical
6.2.1 King Sun Chemical & Pharmaceutical Corporation Information
6.2.2 King Sun Chemical & Pharmaceutical Description and Business Overview
6.2.3 King Sun Chemical & Pharmaceutical Terlipressin Acetate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 King Sun Chemical & Pharmaceutical Terlipressin Acetate Product Portfolio
6.2.5 King Sun Chemical & Pharmaceutical Recent Developments/Updates
6.3 Hybio Pharmaceutical
6.3.1 Hybio Pharmaceutical Corporation Information
6.3.2 Hybio Pharmaceutical Description and Business Overview
6.3.3 Hybio Pharmaceutical Terlipressin Acetate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Hybio Pharmaceutical Terlipressin Acetate Product Portfolio
6.3.5 Hybio Pharmaceutical Recent Developments/Updates
6.4 Harbin Jixianglong
6.4.1 Harbin Jixianglong Corporation Information
6.4.2 Harbin Jixianglong Description and Business Overview
6.4.3 Harbin Jixianglong Terlipressin Acetate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Harbin Jixianglong Terlipressin Acetate Product Portfolio
6.4.5 Harbin Jixianglong Recent Developments/Updates
6.5 Qingdao Guoda
6.5.1 Qingdao Guoda Corporation Information
6.5.2 Qingdao Guoda Description and Business Overview
6.5.3 Qingdao Guoda Terlipressin Acetate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Qingdao Guoda Terlipressin Acetate Product Portfolio
6.5.5 Qingdao Guoda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terlipressin Acetate Industry Chain Analysis
7.2 Terlipressin Acetate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terlipressin Acetate Production Mode & Process
7.4 Terlipressin Acetate Sales and Âé¶¹Ô´´ing
7.4.1 Terlipressin Acetate Sales Channels
7.4.2 Terlipressin Acetate Distributors
7.5 Terlipressin Acetate Customers
8 Terlipressin Acetate Âé¶¹Ô´´ Dynamics
8.1 Terlipressin Acetate Industry Trends
8.2 Terlipressin Acetate Âé¶¹Ô´´ Drivers
8.3 Terlipressin Acetate Âé¶¹Ô´´ Challenges
8.4 Terlipressin Acetate Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Sun Pharmaceutical Industries
King Sun Chemical & Pharmaceutical
Hybio Pharmaceutical
Harbin Jixianglong
Qingdao Guoda
Ìý
Ìý
*If Applicable.